title: Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
authors.forename: Joo Cheol
authors.initials: JC
authors.lastname: Shim
authors.forename: Byeong Moo
authors.initials: BM
authors.lastname: Choe
authors.forename: Jung Gee
authors.initials: JG
authors.lastname: Kim
authors.forename: Young Myo
authors.initials: YM
authors.lastname: Jae
authors.forename: Ho Chan
authors.initials: HC
authors.lastname: Kim
authors.forename: Sung Gon
authors.initials: SG
authors.lastname: Kim
authors.forename: Min Kyung
authors.initials: MK
authors.lastname: Oh
authors.forename: Deanna L
authors.initials: DL
authors.lastname: Kelly
authors.forename: Robert R
authors.initials: RR
authors.lastname: Conley
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D000077152:Olanzapine; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D012189:Retrospective Studies; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D006220:Haloperidol; D018967:Risperidone; D000077152:Olanzapine